Short Title:
Novel Biodosimetry
Responsible HRP Element:
Space Radiation
Funding Status:
Completed - Task completed and produced a deliverable
|
Procurement Mechanism(s):
|
|
Aims:
We plan to extend our previous work by developing optimized multiplex marker panels for human and mouse biodosimetry, validate our approach by comparing our assay to current gold standard cytological methods and then utilize the novel system to assess risks from space radiation and improve our understanding of how these risks are affected by variations in dose rate, dose fractionation and genome stability.
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
Annual and Final Reports
Internal Customers:
None
External Customers:
None
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
Annual Report
Internal Customers:
None
External Customers:
None
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
Annual Report
Internal Customers:
None
External Customers:
None
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
Annual Report
Internal Customers:
None
External Customers:
None